dc.contributor.author |
Paul L. Cary |
dc.coverage.spatial |
Estados Unidos |
dc.date.accessioned |
2016-01-07T15:26:09Z |
dc.date.available |
2016-01-07T15:26:09Z |
dc.identifier.uri |
http://desa1.cejamericas.org:8080/handle/2015/1821 |
dc.description.abstract |
This fact sheet is intended for drug court practitioners who are routinely engaged in the interpretation and evaluation of urine drug testing results for the purpose of participant case adjudication, particularly client sanctioning. Given that most drug courts do not have routine access to biomedical or pharmacological expertise, this fact sheet recommends that the use of urine drug concentrations be eliminated from the court’s decision-making process in order to protect client rights and ensure that evidentiary standards are maintained. |
dc.language.iso |
Inglés |
dc.title |
Drug court practitioner fact sheet. Urine drug concentrations: the scientific rationale for eliminat |
dc.ceja.source |
Fuente: <a href="http://www.ndcrc.org/sites/default/files/urine_drug_concentrations_1.pdf" target="_blank">http://www.ndcrc.org/sites/default/files/urine_drug_concentrations_1.pdf</a> |